{"id":"W42654371","doi":"10.2165/11587820-000000000-00000","title":"Targeting Progressive Neuroaxonal Injury","year":2011,"lang":"en","type":"review","venue":"CNS Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; University of British Columbia; McGill University","funders":"National Institutes of Health; Health Canada; Multiple Sclerosis Society; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Sanofi","keywords":"Neurodegeneration; Medicine; Neuroprotection; Amyotrophic lateral sclerosis; Multiple sclerosis; Disease; Neurology; Neuroscience; Parkinson's disease; Inflammation; Degenerative disease; Pathology; Progressive supranuclear palsy; Immunology; Biology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001019494,0.0005108353,0.001418362,0.0001815077,0.00009555299,0.00002385435,0.0001720744,0.0002518901,0.0007590913],"category_scores_gemma":[0.00005306582,0.0003665218,0.0006084135,0.0002087898,0.00005729097,0.00005037091,0.0001202437,0.000391457,0.001031675],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001166578,"about_ca_system_score_gemma":0.0004901739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000505434,"about_ca_topic_score_gemma":4.731854e-8,"domain_scores_codex":[0.9982189,0.0000914558,0.0004241635,0.0005942241,0.0002544321,0.000416801],"domain_scores_gemma":[0.9987713,0.00003506849,0.0003374447,0.0004391871,0.00007303723,0.0003439504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002376487,0.0002881386,0.00001452056,0.005973127,0.000405116,0.0004836821,0.0000511559,3.475949e-9,2.710414e-7,0.0002133246,0.002594297,0.9899526],"study_design_scores_gemma":[0.0003402677,0.0001451526,0.00001540661,0.00722531,0.002537063,0.00008912594,0.0000100944,0.000001519158,0.000003520051,0.00006055214,0.9892991,0.0002729172],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003837186,0.9927779,0.000005852024,0.00001081334,0.0004319741,0.001202817,0.0001507467,0.0001261555,0.005255366],"genre_scores_gemma":[0.00009092926,0.9961219,0.0004449527,0.0001238823,0.0004738105,0.0004119127,0.0005103673,0.0001140885,0.001708135],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9896797,"threshold_uncertainty_score":0.9998786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04339443308181088,"score_gpt":0.3355078472654068,"score_spread":0.2921134141835959,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}